Live tape
Top 8, mentions 7d13,794NVDA4,542 mentions▲ +0.04GOOGL2,008 mentions▲ +0.04SPY1,680 mentions▲ +0.06QQQ1,523 mentions▲ +0.05AMD1,187 mentions▲ +0.08SPCX1,074 mentions▲ +0.05TSLA932 mentions▲ +0.04SNDK848 mentions▲ +0.05

Equity · Technology

CLBT

NASDAQ

Cellebrite DI (CLBT)

12.46 USD +0.61% vs prior close Nov 6, 2026
Cellebrite DI Ltd. price graph
62 sessions
16 10 12 Aug 6 Nov

The line runs 15.26 USD on 12 August through 12.46 USD on 6 November, on a scale from 10 to 16. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Revenue, year to Dec 2025
475.7M USD
EPS, diluted, year to Dec 2025
0.31 USD
52-week range
10.45 USD – 19.29 USD
Avg volume
188.8K

as of Nov 6, 2026

Have Cellebrite DI (CLBT) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, Cellebrite DI insiders reported 8 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 12 May 2026, show no open-market purchase.

Form 4, 90 days to 10 Nov 2026, newest reported trade 16 Oct 2026

Buys 0Sells 8Net sold $2.80MOther filings 8

Have Cellebrite DI (CLBT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
16 Oct 2026Barter DavidChief Financial OfficerSell12,134136K USD
25 Aug 2026Hogan Thomas E.Sell25,299286K USD
24 Aug 2026GEE DAVID NICHOLASChief Marketing OfficerSell4,32349K USD
21 Aug 2026GEE DAVID NICHOLASChief Marketing OfficerSell2,19825K USD
21 Aug 2026Jewell MarcusGlobal Chief Revenue OfficerSell12,562141K USD
12 Aug 2026GEE DAVID NICHOLASChief Marketing OfficerSell2304K USD
12 Aug 2026Jewell MarcusGlobal Chief Revenue OfficerSell4117K USD
12 Aug 2026Hogan Thomas E.Chief Executive OfficerSell139,7132.1M USD
Sold8 open-market sales196,870$2.80M
8 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Cellebrite DI (CLBT) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
24 Sep 2026Ramji ShivenChief Executive OfficerAward38,505
17 Sep 2026Baudot-Trajtenberg NadineDirectorAward15,190
17 Sep 2026Gruber DafnaDirectorAward15,190
17 Sep 2026Richardson TroyDirectorAward15,190
17 Sep 2026Van Buren BrandonDirectorAward15,190
17 Sep 2026Utsumi RyusukeDirectorAward15,190
17 Sep 2026Domnitz YonatanDirectorAward15,190
17 Sep 2026CLAMMER ADAMDirectorAward15,190

Which funds hold Cellebrite DI (CLBT)?

7 of the 45 institutional funds we track reported a Cellebrite DI position for the quarter ended 30 Jun 2026 — a combined 44.6M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Cellebrite DI (CLBT)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)2,150,23931.4M USD−24.8%
Citadel AdvisorsTrimmed517,1447.6M USD−64.0%
ARK Investment ManagementAdded170,9232.5M USD+35.5%
Two Sigma InvestmentsTrimmed137,3362.0M USD−40.8%
Man GroupNew position39,532577K USD
Point72 Asset ManagementNew position28,645418K USD
AQR Capital ManagementTrimmed13,712200K USD−59.8%
Marshall WaceExited
Millennium ManagementExited
Tudor Investment CorpExited

What has been filed or recorded for Cellebrite DI (CLBT)?

The filings we hold for Cellebrite DI, newest first: 2 fails-to-deliver days and 5 reported financial figures, the latest dated 14 Oct 2026.

What has been filed or recorded for Cellebrite DI (CLBT)?
And
14 Oct 2026Fails to deliverShares failed to deliver99 shares1K USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver643 shares7K USD notional · <0.001% of shares out
31 Dec 2025FinancialsRevenue475.7M USDfiscal year
31 Dec 2025FinancialsNet income78.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS0.31 USDfiscal year
31 Dec 2025FinancialsTotal assets938.9M USDat period end
31 Dec 2025FinancialsTotal equity484.3M USDat period end

Cellebrite DI (CLBT): frequently asked questions

From live data
12.46

What did Cellebrite DI shares close at?

Cellebrite DI closed at 12.46 USD on 6 Nov 2026, up 0.61% on the close before. That is the end-of-day price from Finazon, not a live quote.

475.7M

What is Cellebrite DI’s revenue?

Cellebrite DI reported revenue of 475.7M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

8 sales

Have Cellebrite DI insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, Cellebrite DI insiders reported 8 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 12 May 2026, show no open-market purchase. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

7 of 45

Which funds own Cellebrite DI?

7 of the 45 funds we track reported a Cellebrite DI position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Citadel Advisors and ARK Investment Management. See Funds

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 31 Dec 2025